Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 16 | 5 | 8 | 15 | 18 |
| Gross Profit | 16 | 5 | 8 | 15 | 18 |
| Operating Expenses | 5,070 | 4,014 | 3,697 | 3,570 | 15,073 |
| Operating Income | -5,054 | -4,009 | -3,689 | -3,555 | -15,055 |
| Interest Expense | 29 | 631 | 496 | 507 | 182 |
| Other Income | 267 | -15,763 | 0 | 0 | -417 |
| Pre-tax Income | -4,816 | -20,403 | -4,184 | -4,063 | -15,653 |
| Net Income Continuous | -4,816 | -20,403 | -4,184 | -4,063 | -15,653 |
| Net Income | $-4,816 | $-20,403 | $-4,184 | $-4,063 | $-15,653 |
| EPS Basic Total Ops | -1.37 | -5.77 | -4.99 | -5.10 | -21.44 |
| EPS Basic Continuous Ops | -1.37 | -5.76 | -4.99 | -5.10 | -21.44 |
| EPS Diluted Total Ops | -1.37 | -5.77 | -4.99 | -5.10 | -21.44 |
| EPS Diluted Continuous Ops | -1.37 | -5.76 | -4.99 | -5.10 | -21.44 |
| EBITDA(a) | $-5,028 | $-3,923 | $-3,341 | $-3,208 | $-14,613 |